LFCR - Lifecore Biomedical - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LFCR is currently covered by 1 analysts with an average price target of $6.5. This is a potential upside of $0.74 (50.81%) from yesterday's end of day stock price of $4.31.

Lifecore Biomedical's activity chart (see below) currently has 17 price targets and 18 ratings on display. The stock rating distribution of LFCR is 20% HOLD and 80% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 70% with an average time for these price targets to be met of 130.33 days.

Highest price target for LFCR is $6.5, Lowest price target is $6.5, average price target is $6.5.

Most recent stock forecast was given by from BARRINGTON on 16-Jun-2026. First documented stock forecast 11-Jan-2023.

Best performing analysts who are covering LFCR - Lifecore Biomedical:

Michael Petusky Jacob Johnson Matt Hewitt

Currently out of the existing stock ratings of LFCR, 1 are a HOLD (20%), 4 are a BUY (80%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 24-Mar-2026

$6.5

$1.33 (25.73%)

$6

2 months 23 days ago
(16-Jun-2026)

6/10 (60%)

$1.15 (21.50%)

87

4.64

Hold Since 02-Apr-2024

$6

$0.83 (16.05%)

$6

1 years 8 months 5 days ago
(03-Jan-2025)

3/3 (100%)

$-1.62 (-21.26%)

12

48.76

Buy Since 05-Sep-2024

$10

$4.83 (93.42%)

$8

1 years 9 months 17 days ago
(22-Nov-2024)

1/2 (50%)

$2.69 (36.80%)

292

1.28

Show more analysts

Please expand the browser size to see the chart

What is LFCR (Lifecore Biomedical) average time for price targets to be met?

On average it took 130 days for the stock forecasts to be reached, with an average price target met ratio of 70%.

Which analyst most recently updated their price target on LFCR (Lifecore Biomedical)?

Which analyst has the most public recommendations on LFCR (Lifecore Biomedical)?

has 0 price targets and 0 ratings on LFCR

Which analyst is the currently most bullish on LFCR (Lifecore Biomedical)?

Matt Hewitt with the highest potential upside of $5.6

Which analyst is the currently most reserved on LFCR (Lifecore Biomedical)?

Jacob Johnson with the lowest potential downside of $0.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?